We are live on
!
Find out more
KCM
Kornitzer Capital Management Portfolio holdings
AUM
$4.79B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+29.47%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$4.96B
AUM Growth
+$746M
(+18%)
Cap. Flow
-$245M
Cap. Flow
% of AUM
-4.94%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
537
New
44
Increased
118
Reduced
234
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$22.1M |
| 2 |
Darden Restaurants
DRI
|
+$21.1M |
| 3 |
MasTec
MTZ
|
+$20.3M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$19.7M |
| 5 |
HOLX
Hologic
HOLX
|
+$17.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$31.2M |
| 2 |
Cooper Companies
COO
|
+$26.5M |
| 3 |
Illumina
ILMN
|
+$24.5M |
| 4 |
McDonald's
MCD
|
+$24.4M |
| 5 |
Hershey
HSY
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.69% |
| 2 | Healthcare | 18.48% |
| 3 | Industrials | 11.37% |
| 4 | Consumer Staples | 9.88% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
151
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $11.6M | 0.23% |
193,835
-1,390
| -0.7% | -$74.4K |
|
152
Ecolab
ECL
$77B
| $11.3M | 0.23% |
56,985
-440
| -0.8% | -$85.2K |
|
|
AVLR
153
DELISTED
Avalara, Inc.
AVLR
| $11.3M | 0.23% |
84,732
-6,748
| -7% | -$663K |
|
154
Insulet
PODD
$9.68B
| $11M | 0.22% |
56,388
-71
| -0.1% | -$13.6K |
|
155
Rio Tinto
RIO
$158B
| $10.9M | 0.22% |
194,550
-4,275
| -2% | -$217K |
|
|
MIME
156
DELISTED
Mimecast Limited
MIME
| $10.9M | 0.22% |
260,736
-40,665
| -13% | -$1.6M |
|
157
F5
FFIV
$23.9B
| $10.8M | 0.22% |
77,547
+68,377
| +746% | +$9.21M |
|
158
Paysign
PAYS
$692M
| $10.7M | 0.22% |
1,106,140
+190,830
| +21% | +$1.41M |
|
159
Corpay
CPAY
$27.1B
| $10.7M | 0.21% |
42,346
+18,109
| +75% | +$4.3M |
|
160
Genuine Parts
GPC
$18.1B
| $10.6M | 0.21% |
122,135
+105,445
| +632% | +$8.33M |
|
161
CME Group
CME
$99.6B
| $10.4M | 0.21% |
64,279
-11,301
| -15% | -$2.03M |
|
162
NovoCure
NVCR
$1.91B
| $10.4M | 0.21% |
174,933
+81,193
| +87% | +$5.34M |
|
163
Archer Daniels Midland
ADM
$41.8B
| $10.3M | 0.21% |
257,670
+17,055
| +7% | +$638K |
|
164
STAAR Surgical
STAA
$1.13B
| $10.2M | 0.21% |
165,860
-1,340
| -0.8% | -$54.7K |
|
165
United Parcel Service
UPS
$87B
| $10M | 0.2% |
90,131
-515
| -0.6% | -$51.4K |
|
166
Universal Display
OLED
$3.53B
| $9.99M | 0.2% |
+66,798
| New | +$9.8M |
|
167
Green Dot
GDOT
$749M
| $9.98M | 0.2% |
203,310
-1,520
| -0.7% | -$51.4K |
|
168
Alphabet (Google) Class C
GOOG
$4.17T
| $9.72M | 0.2% |
137,580
-10,120
| -7% | -$683K |
|
169
TSMC
TSM
$2.14T
| $9.61M | 0.19% |
169,281
| – | – |
|
170
Colgate-Palmolive
CL
$69.1B
| $9.6M | 0.19% |
131,030
-6,015
| -4% | -$427K |
|
|
PRO
171
DELISTED
PROS Holdings
PRO
| $9.6M | 0.19% |
216,056
+4,775
| +2% | +$169K |
|
172
Home Depot
HD
$305B
| $9.54M | 0.19% |
38,087
-535
| -1% | -$122K |
|
173
Adaptive Biotechnologies
ADPT
$4B
| $9.51M | 0.19% |
196,500
-1,620
| -0.8% | -$59.1K |
|
174
ASML
ASML
$610B
| $9.47M | 0.19% |
25,741
| – | – |
|
175
DuPont de Nemours
DD
$16.8B
| $9.44M | 0.19% |
141,603
-15,473
| -10% | -$904K |
|
Similar funds
TI
ATPW
PTC
LPPI
BCI
SAMU
SHCM
SP
Kornitzer Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Kornitzer Capital Management held 537 positions worth $4.96B, up 18% from $4.21B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Kornitzer Capital Management withdrew a net $245M in Q2 2020, closing 44 positions and reducing 234 holdings. Its most notable exit was Align Technology, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Kornitzer Capital Management opened a new position in Darden Restaurants worth $22.5M.
- Kornitzer Capital Management's largest Q2 2020 buy was Darden Restaurants: 297,116 shares worth $22.5M.
- Kornitzer Capital Management added most to Ligand Pharmaceuticals in Q2 2020, an estimated $22.1M increase.
- Kornitzer Capital Management's biggest Q2 2020 reduction was Bio-Techne, cutting an estimated $31.2M.
- Kornitzer Capital Management fully exited Align Technology in Q2 2020, selling an estimated $19.8M.
- Kornitzer Capital Management's ten largest holdings make up 13% of its $4.96B portfolio in Q2 2020.
- Kornitzer Capital Management opened 44 new positions and closed 44 in Q2 2020.
- Kornitzer Capital Management's portfolio value rose 18% quarter-over-quarter to $4.96B.
Based on Kornitzer Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.